About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
C
FDA Approval of Zanubrutinib in R/R FL: What You Need to Know
By
Christopher Flowers
5 Videos
514 views
March 15, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Featured Video
37:21
Amgen Sponsorship
New Approval for Frontline Consolidation in Patients with CD19-posit…
Feat.
J. Mccloskey
Related Content
AUTOPLAY
ON
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
Feat.
B. D. Cheson
19:14
SOHO Brazil 2024
FL: How Do I Deal With Relapse?
Feat.
B. Kahl
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
13:40
UChicago Medicine
Summary of Bispecific Antibodies for Follicular Lymphoma
Feat.
D. Russler-Germain
13:56
SOHO 2023 Eleventh Annual Meeting
Follicular Lymphoma Management: What Is the New Order?
Feat.
B. Kahl
16:34
Jennifer Amengual
Top 5 Lymphoma Abstracts From ASH
27:51
Louisville Hematology Highlights
Summary of Recent Advances in Follicular Lymphoma
Feat.
S. Gaballa
20:34
UChicago Medicine
Sequencing of Bispecifics With Other Therapies in DLBCL
Feat.
E. Budde
14:34
Northwestern Medicine Oncology and Hematology
EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial
Feat.
L. Gordon
14:01
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
Feat.
M. Gomes da Silva
04:32
Yasmin Karimi
FDA Approval of Epcoritamab in R/R FL: What You Need to Know
08:28
Bruce D. Cheson
Tazemetostat in R/R FL: Impact of EZH2 Mutational Status on PFS
09:48
Erin Mulvey
Tazemetostat in Older Frail Adults With Follicular Lymphoma
31:12
UChicago Medicine
Practice-Changing Abstracts in NHL and HL From ASH 2023
Feat.
S. Smith
19:20
Mitchell Smith
Treatment Landscape in Follicular Lymphoma
17:07
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Comparative Review of Toxicities and Their…
Feat.
M. Minnema
18:15
UChicago Medicine
The Next Frontier of Targeted Therapy in Lymphoma
Feat.
K. Maddocks
25:22
Integrity CE
Treatment Updates and Management of Non-Hodgkin Lymphomas
Feat.
D. Wallace,
M. Cortese
15:32
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Current Clinical Management of Follicular Lymphoma
Feat.
B. Ferhanoğlu
19:46
Scripps Health
Management of Indolent NHL
Feat.
E. Brem